No abstract available
MeSH terms
-
Aged
-
Antibodies, Monoclonal, Humanized* / adverse effects
-
Antibodies, Monoclonal, Humanized* / therapeutic use
-
Diabetes Mellitus, Type 1* / complications
-
Diabetes Mellitus, Type 1* / drug therapy
-
Diabetic Ketoacidosis* / chemically induced
-
Esophageal Neoplasms* / drug therapy
-
Esophageal Squamous Cell Carcinoma* / drug therapy
-
Humans
-
Male
-
Middle Aged
Substances
-
sintilimab
-
Antibodies, Monoclonal, Humanized